A randomized trial comparing triiodothyronine (T3) with thyroxine (T4) for hemodynamically unstable brain-dead organ donors.
Rajat DharEmily StahlschmidtYan YanGary MarklinPublished in: Clinical transplantation (2019)
Infusion of T3 does not appear to confer significant hemodynamic or cardiac benefits over T4 for hemodynamic unstable BD organ donors.